Newsfeeds - Spark Newswire

4 minute read

Reported Late Tuesday Feb. 28, Regeneron Pharmaceuticals And Sanofi Announce Kevzara Approved By FDA As First And Only Biologic Indicated For Patients With Polymyalgia Rheumatica

Today, 2:40 PM

Three times more patients treated with Kevzara achieved sustained remission compared to placebo in Phase 3 trial Kevzara now approved to treat two chronic inflammatory disorders TARRYTOWN, N.Y. and CAMBRIDGE,

REGN

5 minute read

‘New Phase 3 Data Presented At WORLDSymposium Reinforce Nexviazyme As Potential New Standard Of Care For All People Living With Late-Onset Pompe Disease’

By Happy Mohamed

Today, 2:40 PM

New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with

SNY

1 minute read

FDA Approves Sanofi’s Hemophilia A Therapy Offering Significant Bleed Protection

By Vandana Singh

Today, 2:40 PM

SNY

1 minute read

FDA
News

Earlier, Sanofi Announced FDA Approved Once-Weekly Altuviiio, New Class of Factor VIII Therapy For Hemophilia A That Offers Significant Bleed Protection

By Charles Gross

Today, 2:40 PM

The U.S. Food and Drug Administration (FDA) has approved ALTUVIIIO™ [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], previously referred to as efanesoctocog alfa, a first-in-class, high-sustained factor VIII replacement therapy.The U.S.

SNY

1 minute read

Nepal Reported Outbreak Of Highly Pathogenic H5N1 Bird Flu On Farm

By Happy Mohamed

Today, 2:40 PM

- Reuters

GSK

1 minute read

Sanofi Expects Moderate 2023 Profit Growth On Dupixent Demand, But Dampened By Aubagio Generics Competition

By Vandana Singh

Today, 2:40 PM

Sanofi SA (NASDAQ:SNY) forecasts 2023 adjusted earnings per share to grow by a “low single-digit” percentage, not considering an expected negative…

SNY

1 minute read

Fear & Greed Index Remains In ‘Greed’ Zone As Nasdaq Record Sharp Gains For Fourth Straight Week

By Lisa Levin

Today, 2:40 PM

The CNN Money Fear and Greed index showed some decline in overall sentiment among US investors. US stocks closed mostly higher on Thursday, with the tech-laden Nasdaq index leading the rally. Investors digested the Fed's policy decision and comments from Federal Reserve Chair Jerome Powell on Wednesday.

5 minute read

February PDUFA Catalysts Biotech Investors Must Know: Sanofi’s Bleeding Disorder Drug, Regeneron’s Twin Eylea Label Expansions, 3 Delayed Approvals And More

By Shanthi Rexaline

Today, 2:40 PM

The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new molecular entities for the year.

APLS

1 minute read

World Organization For Animal Health Says Bolivia Reports Outbreaks Of Highly Pathogenic Bird Flu In Poultry

By Happy Mohamed

Today, 2:40 PM

- Reuters

GNBT

5 minute read

Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch

By Shanthi Rexaline

Today, 2:40 PM

With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed.

AAPL